A cohomology-based Gromov-Hausdorff metric approach for quantifying molecular similarity

We introduce, for the first time, a cohomology-based Gromov-Hausdorff ultrametric method to analyze 1-dimensional and higher-dimensional (co)homology groups, focusing on loops, voids, and higher-dimensional cavity structures in simplicial complexes, to address typical clustering questions arising in molecular data analysis. The Gromov-Hausdorff distance quantifies the dissimilarity between two metric spaces. In this framework, molecules are represented as simplicial complexes, and their cohomology vector spaces are computed to capture intrinsic topological invariants encoding loop and cavity structures. These vector spaces are equipped with a suitable distance measure, enabling the computation of the Gromov-Hausdorff ultrametric to evaluate structural dissimilarities. We demonstrate the methodology using organic-inorganic halide perovskite (OIHP) structures. The results highlight the effectiveness of this approach in clustering various molecular structures. By incorporating geometric information, our method provides deeper insights compared to traditional persistent homology techniques.

Topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction

Recently, therapeutic peptides have demonstrated great promise for cancer treatment. To explore powerful anticancer peptides, artificial intelligence (AI)-based approaches have been developed to systematically screen potential candidates. However, the lack of efficient featurization of peptides has become a bottleneck for these machine-learning models. In this paper, we propose a topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction. Our Top-ML employs peptide topological features derived from its sequence "connection" information characterized by vector and spectral descriptors. Our Top-ML model has been validated on two widely used AntiCP 2.0 benchmark datasets and has achieved state-of-the-art performance. Our results highlight the potential of leveraging novel topology-based featurization to accelerate the identification of anticancer peptides.